@article{5a11fb21fc254b2faa9a62eeae89cd96,
title = "Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial",
keywords = "HUMAN CARTILAGE GLYCOPROTEIN-39, SERUM YKL-40, RADIOGRAPHIC PROGRESSION, COMBINATION THERAPY, PERIPHERAL-BLOOD, ACTIVITY SCORES, FOLLOW-UP, MHC CLASS, JOINT, INFLAMMATION, 3121 General medicine, internal medicine and other clinical medicine, 3111 Biomedicine",
author = "Tuija Vaananen and Katriina Vuolteenaho and Hannu Kautiainen and Riina Nieminen and Timo Mottonen and Pekka Hannonen and Markku Korpela and Kauppi, {Markku J.} and Kari Laiho and Oili Kaipiainen-Seppanen and Riitta Luosujarvi and Tea Uusitalo and Toini Uutela and Marjatta Leirisalo-Repo and Eeva Moilanen and {NEO-RACo Study Grp}",
year = "2017",
month = aug,
day = "25",
doi = "10.1371/journal.pone.0183294",
language = "English",
volume = "12",
journal = "PLoS One",
issn = "1932-6203",
publisher = "PUBLIC LIBRARY OF SCIENCE",
number = "8",
}